Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA accepts for review Picovir NDA for use in the common cold

Oct. 4, 2001

Novel compounds for HCV infection patented by Schering-Plough

Oct. 3, 2001

MTP inhibitors from Advanced Medicine reportedly useful for atherosclerosis

Oct. 3, 2001

Newly claimed Rho kinase inhibitors with wide range of therapeutic applications

Oct. 3, 2001

Advanced Medicine discloses new nicotinic acetylcholine receptor modulators and use as analgesics

Oct. 3, 2001

Antiulcer agents from Sankyo inhibit H+/K+-ATPase and H. pylori

Oct. 3, 2001

Integrin antagonists under early development at Merck KGaA

Oct. 3, 2001

BMS discloses new series and uses of cannabinoid receptor modulators

Oct. 3, 2001

Teijin describes preparation and use of new chymase inhibitors

Oct. 3, 2001

Pamidronate reduces bone loss in men on prostate cancer treatment

Oct. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...